# Evaluation of the Diagnostic Potential of Artificial Intelligence-assisted Fecal Microbiome Testing for Inflammatory Bowel Disease

> **NCT05797207** · NA · UNKNOWN · sponsor: **Istanbul Medipol University Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Inflammatory Bowel Diseases
- Microbiota
- Colonoscopy

## Interventions

- **DIAGNOSTIC_TEST:** Artificial Intelligence-assisted Fecal Microbiome Testing
- **PROCEDURE:** Colonoscopy

## Key facts

- **NCT ID:** NCT05797207
- **Lead sponsor:** Istanbul Medipol University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-04-10
- **Primary completion:** 2024-02-28
- **Final completion:** 2024-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2023-04-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05797207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05797207, "Evaluation of the Diagnostic Potential of Artificial Intelligence-assisted Fecal Microbiome Testing for Inflammatory Bowel Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05797207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*